Funding Focus IFCR is actively funding scientific and clinical CDKL5 research with a revenue range of 1M-10M and a recent leadership appointment, signaling openness to partnerships and sponsorships with biotech firms, contract research organizations, and philanthropic funders seeking collaboration and visibility in rare disease research.

Awareness & Outreach The organization prioritizes raising awareness of CDKL5 in medical and lay communities, presenting an opportunity for partnerships with medical communications firms, patient advocacy groups, and digital marketing agencies to co-create educational programs and targeted outreach.

Tech Stack Utilizes cloud and web technologies (AWS, WordPress, WP Engine) and analytics/ads tools (Google AdSense) along with engagement platforms (Tawk.to). Potential for collaboration on digital presence, donor/member portals, and targeted fundraising campaigns using these technologies.

Leadership & Access Recent appointment of an Executive Director indicates leadership growth and potential for larger strategic initiatives. This may open doors for executive-level partnerships, consulting engagements, and joint grant-writing projects with industry players targeting rare disease funding.

Impact & Beneficiaries Mission to support families and provide up-to-date treatment information suggests opportunities for stakeholder-facing solutions such as patient education platforms, telehealth resources, and community engagement tools that align with their emphasis on quality of life and care coordination.